ChemoCentryx
CCXI
#3542
Rank
NZ$6.47 B
Marketcap
NZ$90.01
Share price
0.00%
Change (1 day)
32.03%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.27. In 2021 the company made an earnings per share (EPS) of NZ-$3.27 a decrease over its 2020 EPS that were of NZ-$1.40.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-14.08%
2021NZ-$3.27133.33%
2020NZ-$1.40-16.49%
2019NZ-$1.6827.63%
2018NZ-$1.32-305.41%
2017NZ$0.64-142.53%
2016NZ-$1.51-19.44%
2015NZ-$1.87-0%
2014NZ-$1.8713.68%
2013NZ-$1.64-16.67%
2012NZ-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.28-689.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.35-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.14-226.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.81-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.03-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.65-486.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.14-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.52-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.15-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel